Medtecs International Corporation Limited (9103.TW)
TWD 5.04
(-1.95%)
TWD 5.04
(-1.95%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 37.35 Million USD | 2.65% |
| 2022 | 36.39 Million USD | -26.71% |
| 2021 | 49.66 Million USD | -7.49% |
| 2020 | 53.67 Million USD | 41.84% |
| 2019 | 37.84 Million USD | 11.8% |
| 2018 | 33.85 Million USD | -1.35% |
| 2017 | 34.31 Million USD | -1.26% |
| 2016 | 34.74 Million USD | -3.46% |
| 2015 | 35.99 Million USD | -1.6% |
| 2014 | 36.58 Million USD | 3.95% |
| 2013 | 35.19 Million USD | 1.31% |
| 2012 | 34.73 Million USD | 5.93% |
| 2011 | 32.79 Million USD | 7.9% |
| 2010 | 30.38 Million USD | 10.15% |
| 2009 | 27.58 Million USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 37.9 Million USD | 1.45% |
| 2023 Q4 | 37.35 Million USD | -5.47% |
| 2023 FY | 37.35 Million USD | 2.65% |
| 2023 Q2 | 39.52 Million USD | 8.59% |
| 2022 FY | 36.39 Million USD | -26.71% |
| 2022 Q4 | 36.39 Million USD | -25.25% |
| 2022 Q2 | 48.68 Million USD | -1.96% |
| 2021 Q4 | 49.66 Million USD | -0.56% |
| 2021 FY | 49.66 Million USD | -7.49% |
| 2021 Q2 | 49.94 Million USD | -6.96% |
| 2020 FY | 53.67 Million USD | 41.84% |
| 2020 Q4 | 53.67 Million USD | 42.43% |
| 2020 Q2 | 37.68 Million USD | -0.41% |
| 2019 FY | 37.84 Million USD | 11.8% |
| 2019 Q4 | 37.84 Million USD | 12.08% |
| 2019 Q2 | 33.76 Million USD | -0.25% |
| 2018 Q2 | 35.22 Million USD | 2.67% |
| 2018 Q4 | 33.85 Million USD | -3.91% |
| 2018 FY | 33.85 Million USD | -1.35% |
| 2017 Q2 | 35.45 Million USD | 2.04% |
| 2017 Q4 | 34.31 Million USD | -3.23% |
| 2017 FY | 34.31 Million USD | -1.26% |
| 2016 Q4 | 34.74 Million USD | -4.19% |
| 2016 FY | 34.74 Million USD | -3.46% |
| 2016 Q2 | 36.26 Million USD | 0.76% |
| 2015 Q2 | 36.04 Million USD | -1.47% |
| 2015 FY | 35.99 Million USD | -1.6% |
| 2015 Q4 | 35.99 Million USD | -0.13% |
| 2014 FY | 36.58 Million USD | 3.95% |
| 2014 Q4 | 36.58 Million USD | -0.1% |
| 2014 Q2 | 36.61 Million USD | 4.05% |
| 2013 FY | 35.19 Million USD | 1.31% |
| 2013 Q4 | 35.19 Million USD | -2.99% |
| 2013 Q2 | 36.27 Million USD | 4.43% |
| 2012 FY | 34.73 Million USD | 5.93% |
| 2012 Q4 | 34.73 Million USD | 4.63% |
| 2012 Q2 | 33.19 Million USD | 1.24% |
| 2011 FY | 32.79 Million USD | 7.9% |
| 2011 Q2 | 32.87 Million USD | 8.17% |
| 2011 Q4 | 32.79 Million USD | -0.25% |
| 2010 Q2 | 29.33 Million USD | 6.33% |
| 2010 FY | 30.38 Million USD | 10.15% |
| 2010 Q4 | 30.38 Million USD | 3.6% |
| 2009 Q2 | 24.62 Million USD | 0.0% |
| 2009 Q4 | 27.58 Million USD | 12.04% |
| 2009 FY | 27.58 Million USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Nang Kuang Pharmaceutical Co., Ltd. | 705.32 Million TWD | 94.703% |
| Maxigen Biotech Inc. | 85.18 Million TWD | 56.144% |
| SciVision Biotech Inc. | 87.25 Million TWD | 57.183% |
| Bionime Corporation | 491.25 Million TWD | 92.395% |
| Pegavision Corporation | 583.47 Million TWD | 93.597% |
| Visco Vision Inc. | 606.06 Million TWD | 93.836% |